Chuck Akre's compounder shop — a handful of high-return franchises held for the very long term.
| # | Holding | Our call | % of book | Value | Shares | QoQ |
|---|---|---|---|---|---|---|
| 1 | MA | Buy | 18.6% | $1.14B | 2.28M | Trimmed-24% |
| 2 | BN | — | 11.3% | $689M | 17.0M | Trimmed-37% |
| 3 | KKR | Hold | 10.2% | $621M | 6.72M | Trimmed-17% |
| 4 | MCO | Hold | 8.9% | $544M | 1.25M | Trimmed-28% |
| 5 | V | Hold | 8.1% | $495M | 1.64M | Trimmed-39% |
| 6 | ROP | Buy | 7.3% | $445M | 1.26M | Added+14% |
| 7 | COSTAR GROUP INC | — | 6.8% | $417M | 10.3M | Added+8% |
| 8 | FICO | Hold | 6.3% | $388M | 364K | Added+31% |
| 9 | ORLY | Hold | 5.9% | $359M | 3.89M | Trimmed-42% |
| 10 | COPART INC | — | 4.3% | $266M | 8.00M | Added+2% |
| 11 | ABNB | Hold | 4.2% | $257M | 2.03M | Trimmed-41% |
| 12 | CCC | — | 3.1% | $189M | 31.5M | Added+27% |
| 13 | CRM | Buy | 2.2% | $134M | 718K | NEW |
| 14 | NOW | Buy | 1.9% | $115M | 1.10M | NEW |
| 15 | GSHD | — | 0.3% | $18.9M | 443K | Added+19% |
| 16 | CRMCall | Buy | — | $18.7M | 100K | NEW |
| 17 | SOPH | — | 0.3% | $18.4M | 3.72M | — |
| 18 | AMT | Hold | 0.1% | $8.76M | 50.8K | Trimmed-80% |
| 19 | PRM | Hold | 0.1% | $6.11M | 250K | NEW |
| 20 | BRKB | — | 0.1% | $4.95M | 10.3K | Trimmed-13% |
Source: SEC Form 13F-HR. Positions are as-of quarter end (filed up to 45 days later) and cover US-listed equities only — shorts, non-US listings and most derivatives don’t appear. Values as reported by the filer. “Our call” is TENK/calls’s independent SEC-grounded verdict, not the fund’s view.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.